These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37538343)

  • 21. Most families tend to realize progress of Alzheimer's disease when behavioural and psychological symptoms are obvious.
    Honjo Y; Ide K; Takechi H
    Psychogeriatrics; 2022 May; 22(3):317-323. PubMed ID: 35146847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
    J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate.
    van Dyck CH; Arnsten AFT; Padala PR; Brawman-Mintzer O; Lerner AJ; Porsteinsson AP; Scherer RW; Levey AI; Herrmann N; Jamil N; Mintzer JE; Lanctôt KL; Rosenberg PB
    Am J Geriatr Psychiatry; 2021 Jan; 29(1):51-62. PubMed ID: 32461027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Cerebral Small Vessel Disease Burden with Neuropsychiatric Symptoms in Non-Demented Elderly: A Longitudinal Study.
    Cao QL; Sun Y; Hu H; Wang ZT; Tan L; Yu JT;
    J Alzheimers Dis; 2022; 89(2):583-592. PubMed ID: 35912738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer's disease.
    Wang HJ; Chinna-Meyyappan A; Feldman OJ; Lanctôt KL
    Expert Opin Emerg Drugs; 2024 Sep; 29(3):289-303. PubMed ID: 38822731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of rivastigmine treatment on the neuropsychiatric and behavioral disturbances of nursing home residents with moderate to severe probable Alzheimer's disease: a 26-week, multicenter, open-label study.
    Cummings JL; Koumaras B; Chen M; Mirski D;
    Am J Geriatr Pharmacother; 2005 Sep; 3(3):137-48. PubMed ID: 16257816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of anosognosia and neuropsychiatric symptoms on the quality of life of patients with Alzheimer's disease: a 24-month follow-up study.
    Conde-Sala JL; Turró-Garriga O; Piñán-Hernández S; Portellano-Ortiz C; Viñas-Diez V; Gascón-Bayarri J; Reñé-Ramírez R
    Int J Geriatr Psychiatry; 2016 Feb; 31(2):109-19. PubMed ID: 25963296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of the Neuropsychiatric Inventory Questionnaire (NPI-Q) in the assessment of a sample of patients with Alzheimer's disease in Chile.
    Musa G; Henríquez F; Muñoz-Neira C; Delgado C; Lillo P; Slachevsky A
    Dement Neuropsychol; 2017; 11(2):129-136. PubMed ID: 29213504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis.
    Zhao QF; Tan L; Wang HF; Jiang T; Tan MS; Tan L; Xu W; Li JQ; Wang J; Lai TJ; Yu JT
    J Affect Disord; 2016 Jan; 190():264-271. PubMed ID: 26540080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropsychiatric symptoms in patients with vascular dementia in mainland China.
    Jin YL; Zhang H; Gao YZ; Shu M; Xu Y; Liu X; Zhang SM; Zou CY; Cao J; Xiong RH
    Transl Neurosci; 2015; 6(1):157-161. PubMed ID: 28123799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysis.
    Eikelboom WS; Pan M; Ossenkoppele R; Coesmans M; Gatchel JR; Ismail Z; Lanctôt KL; Fischer CE; Mortby ME; van den Berg E; Papma JM
    Alzheimers Res Ther; 2022 Apr; 14(1):48. PubMed ID: 35379344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The reporting of neuropsychiatric symptoms in electronic health records of individuals with Alzheimer's disease: a natural language processing study.
    Eikelboom WS; Singleton EH; van den Berg E; de Boer C; Coesmans M; Goudzwaard JA; Vijverberg EGB; Pan M; Gouw C; Mol MO; Gillissen F; Fieldhouse JLP; Pijnenburg YAL; van der Flier WM; van Swieten JC; Ossenkoppele R; Kors JA; Papma JM
    Alzheimers Res Ther; 2023 May; 15(1):94. PubMed ID: 37173801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.
    Kaufer DI; Cummings JL; Christine D; Bray T; Castellon S; Masterman D; MacMillan A; Ketchel P; DeKosky ST
    J Am Geriatr Soc; 1998 Feb; 46(2):210-5. PubMed ID: 9475452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer's disease during the COVID-19 lockdown.
    Lara B; Carnes A; Dakterzada F; Benitez I; Piñol-Ripoll G
    Eur J Neurol; 2020 Sep; 27(9):1744-1747. PubMed ID: 32449791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychiatric symptoms and activities of daily living in Alzheimer's disease: ALSOVA 5-year follow-up study.
    Saari T; Hallikainen I; Hintsa T; Koivisto AM
    Int Psychogeriatr; 2020 Jun; 32(6):741-751. PubMed ID: 31656211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    Rosenberg PB; Lanctôt KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R
    J Alzheimers Dis; 2016 Aug; 54(1):373-81. PubMed ID: 27567808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychiatric Symptoms of Alzheimer's Disease and Caregiver Burden.
    Iravani B; Abdollahi E; Eslamdoust-Siahestalkhi F; Soleimani R
    Front Neurol; 2022; 13():877143. PubMed ID: 35968317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease.
    Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D
    Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.